See also this year's filing and all EDGAR filings for this company.
PDF Report 0001597553_2022_Sage_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001597553, Sage Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,800,643,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,016,000 |
| 3 | remainder_Assets | 21,629,000 |
| 4 | LiabilitiesCurrent | 85,193,000 |
| 5 | LiabilitiesNoncurrent | 11,064,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 181,752,909 |
| 9 | ResearchAndDevelopmentExpense | 280,778,061 |
| 10 | remainder_Expenses | 26,706,513 |
| 11 | remainder_Revenues | 1,107,859,974 |
| 12 | remainder_NetIncome | 1,552,382 |
| 13 | remainder_ComprehensiveNetIncome | -2,859,482 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,825,288,000 |
| 1 | Liabilities | 96,257,000 |
| 2 | Expenses | 489,237,483 |
| 3 | Revenues | 1,107,859,974 |
| 4 | StockholdersEquity | 1,729,031,000 |
| 5 | NetIncome | 620,174,873 |
| 6 | ComprehensiveNetIncome | 618,745,132 |
| 7 | BaseVar | 1,761,527,160 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.57 |
| 9 | EconomicCapitalRatio | 4.83 |
Edgar->Model Mapping
Feature Distribution
Change over Time
